Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary indicates positive financial performance with revenue, gross profit margin, net income, and operating cash flow all showing year-over-year improvements. The backlog increase suggests strong future revenue potential. Despite the lack of discussion on strategic initiatives, risks, and shareholder returns, the financial metrics and improved operational efficiencies provide a positive outlook. Given the market cap, the stock is likely to experience a positive movement of 2% to 8% over the next two weeks.
Revenue Granite Construction reported a revenue of $1.2 billion for Q1 2026, representing a 5% increase year-over-year. The growth was attributed to higher demand in the transportation and water infrastructure sectors.
Gross Profit Margin The gross profit margin improved to 12.5%, up from 11.8% in Q1 2025. This improvement was driven by better project execution and cost management.
Net Income Net income for the quarter was $45 million, a 15% increase compared to $39 million in Q1 2025. The increase was due to higher revenues and improved operational efficiencies.
Operating Cash Flow Operating cash flow stood at $95 million, up 20% year-over-year from $79 million. This was primarily due to improved collections and better working capital management.
Backlog The backlog at the end of Q1 2026 was $4.8 billion, a 10% increase from $4.35 billion in Q1 2025. The growth was driven by strong project wins in core markets.
The selected topic was not discussed during the call.
The selected topic was not discussed during the call.
The selected topic was not discussed during the call.
The selected topic was not discussed during the call.
The earnings call summary indicates positive financial performance with revenue, gross profit margin, net income, and operating cash flow all showing year-over-year improvements. The backlog increase suggests strong future revenue potential. Despite the lack of discussion on strategic initiatives, risks, and shareholder returns, the financial metrics and improved operational efficiencies provide a positive outlook. Given the market cap, the stock is likely to experience a positive movement of 2% to 8% over the next two weeks.
The earnings call reveals a mixed performance with significant declines in the antigen business, disappointing gross margins, and uncertainty in Chinese sales resumption. Despite some positive developments in the QAPs business and cost control, the lack of profitability forecast for Q4 and unclear management responses in the Q&A section contribute to a negative outlook. The market cap suggests a moderate reaction, leading to a prediction of a -2% to -8% stock price movement.
The earnings call summary highlights a strong financial performance with increased cash gross profit and aggregate reserves. The Q&A session reveals positive sentiment from analysts, with management expressing confidence in growth, M&A strategy, and margin improvements. The company's strategic initiatives, such as federal opportunities and best value contracts, further support a positive outlook. The market cap suggests a moderate reaction, leading to a predicted stock price movement in the positive range (2% to 8%).
The earnings call highlights strong financial performance with significant year-over-year improvements in revenue, gross profit, net income, and EBITDA, driven by acquisitions and operational efficiency. The Q&A section supports this positive outlook with expectations of continued growth and margin expansion, despite some uncertainties like weather impact. Revised guidance and successful acquisition integration further reinforce a positive sentiment. Given the company's market cap, the stock price is likely to experience a positive movement in the 2% to 8% range over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.